Responses of guinea pig umbilical vasculature to vasoactive drugs.
D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000813:Anilides / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001679:Biogenic Amines / Q000494:pharmacology*; D001920:Bradykinin / Q000494:pharmacology; D002934:Cinnamates / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D003080:Cold Temperature; D003913:Dextroamphetamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005260:Female; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000031:analogs & derivatives / Q000494:pharmacology; D008694:Methamphetamine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011433:Propranolol / Q000494:pharmacology; D011941:Receptors, Adrenergic; D012701:Serotonin / Q000494:pharmacology; D013440:Sulfides / Q000494:pharmacology; D014309:Tripelennamine / Q000494:pharmacology; D014469:Umbilical Arteries / Q000187:drug effects*; D014471:Umbilical Veins / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000813:Anilides; D001679:Biogenic Amines; D002934:Cinnamates; D010455:Peptides; D011941:Receptors, Adrenergic; D013440:Sulfides; D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D000804:Angiotensin II; D012701:Serotonin; D014309:Tripelennamine; D008694:Methamphetamine; D001285:Atropine; D006632:Histamine; D008238:Lysergic Acid Diethylamide; D011433:Propranolol; D003042:Cocaine; D007545:Isoproterenol; D000109:Acetylcholine; D001920:Bradykinin; D003913:Dextroamphetamine; D009638:Norepinephrine